Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-25-079244
Filing Date
2025-08-15
Accepted
2025-08-15 16:14:52
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2522230d6_defa14a.htm DEFA14A 21891
  Complete submission text file 0001104659-25-079244.txt   22957
Mailing Address YALELAAN 62 UTRECHT P7 3584 CM
Business Address YALELAAN 62 UTRECHT P7 3584 CM 31 6 3000 3035
LAVA Therapeutics NV (Filer) CIK: 0001840748 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40241 | Film No.: 251224797
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)